CTCynthia C. Taub

Cynthia C. Taub

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Cynthia C. Taub has a total of 192 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • The Impact of High-Altitude Training on Cardiac Performance in Adolescent Athletes

    by Yunchuan Ding, Mengmeng Ji, Yang Yang, Jian Zhang, Qinghui Wang, Yuman Li, Wenqian Wu, Qing He, Matthew K. Armstrong, Tom D. Brutsaert, et al.

  • Open Access

    Glucose Disposal Rate: A Novel Measure of Insulin Resistance Associated With Myocardial Fibrosis and Incident Heart Failure

    by Syed Bukhari, Yaa A. Kwapong, Lisa R. Yanek, Erin D. Michos, Joao A. C. Lima, Wendy S. Post, Cynthia C. Taub, Kavita Sharma, Monica Mukherjee, Benjamin H. Freed, et al.

    Background: Heart failure (HF) is increasingly driven by cardiometabolic risk factors such as obesity and insulin resistance. The estimated glucose disposal rate (eGDR) is a validated surrogate marker of insulin resistance. Reduced eGDR, reflecting higher insulin resistance, has been linked to cardiovascular disease, but its associations with myocardial fibrosis and HF remain unclear. Methods: The study included 6025 participants in MESA (Multi‐Ethnic Study of Atherosclerosis) free of HF at exam 2 (2002–2004). eGDR was calculated using body mass index, hypertension, and hemoglobin A1c. Cardiac magnetic resonance imaging (2010–2012) assessed left ventricular ejection fraction and myocardial fibrosis by late gadolinium enhancement. Associations of baseline eGDR with incident HF were evaluated using Cox models, stratified by diabetes. Results: Over a mean follow‐up of 14±5 years, 404 participants developed HF. eGDR was inversely associated with incident HF (adjusted hazard ratio [HR] per unit decrease, 1.28 [95% CI, 1.22–1.35]), a relationship that persisted regardless of diabetes status and was more pronounced for HF with preserved ejection fraction (n=200; adjusted HR per unit decrease, 1.36 [95% CI, 1.27–1.45]) than HF with reduced ejection fraction (n=168; HR, 1.19 [95% CI, 1.11–1.27]). Lower eGDR was also associated with higher left ventricular ejection fraction (n=2899; β=0.16, [95% CI, 0.03–0.28]) and higher odds of myocardial fibrosis (n=1780; adjusted odds ratio, 1.27 [95% CI, 1.16–1.41]). Conclusions: Lower eGDR is independently associated with subclinical myocardial damage and incident HF, highlighting insulin resistance as a key driver of adverse remodeling and a potential marker for early HF risk stratification and prevention.


  • Open Access

    Sex‐Specific Prognostic Value of Left Atrioventricular Coupling Index in Acute Coronary Syndrome: Insights From Artificial Intelligence‐Enhanced 3‐Dimensional Echocardiography

    by Siwen Qin, Difei Li, Guanming Qi, Min Ju, Qin Feng, Jingshu Sun, Ling Yue, Wei Feng, Yanchao Zhang, Shuang Guan, et al.

    Background: Left atrioventricular coupling index (LACI) has emerged as a prognostic biomarker, but its sex‐specific relevance in acute coronary syndrome remains unclear. Methods: This retrospective cohort included 880 patients with acute coronary syndrome (625 men; 255 women) undergoing percutaneous coronary intervention between February 2022 and June 2023. LACI was automatically quantified from 3‐dimensional echocardiography using an artificial intellgience‐based dynamic heart model. Patients were stratified by sex‐specific median LACI values and followed for major adverse cardiovascular events. Cox proportional hazards and Fine–Gray competing risk models evaluated associations between LACI and outcomes. A sensitivity analysis was performed in 3 ways: (1) using propensity score matching, (2) excluding patients with atrial fibrillation, and (3) repeating propensity score matching in the cohort after excluding patients with atrial fibrillation. Results were verified in 3 independent cohorts: 285 internal validation, 124 coronary computed tomography angiography, and 128 external 3‐dimensional echocardiography cohorts. Results: Over a median 18‐month follow‐up, 219 major adverse cardiovascular events occurred. Women had significantly higher median LACI values than men. LACI was significantly associated with increased major adverse cardiovascular event risk in men (hazard ratio [HR], 1.23 [95% CI, 1.03–1.46]; P =0.020; P for interaction=0.027) but not in women. Restricted cubic spline analysis demonstrated a linear dose–response association in men. Fine–Gray analysis demonstrated a significant association between LACI and major adverse cardiovascular events in men. Findings remained consistent after AF exclusion, PSM, and across all validation cohorts. Conclusions: Artificial intelligence‐derived LACI from 3‐dimensional echocardiography demonstrates clear sex‐specific prognostic value in acute coronary syndrome, and is significantly associated with adverse cardiovascular outcomes in men but not in women. These results support sex‐specific risk stratification and highlight the clinical relevance of atrioventricular coupling assessment. Registration: URL: https://www.chictr.org.cn/ . Unique identifier: ChiCTR2500099592.

  • Open Access

    Left atrial reverse remodeling in patients with persistent atrial fibrillation and HFpEF following radiofrequency ablation: prospective evaluation with echocardiographic atrial analysis

    by Yan Chen, Mingxia Li, Xiaoxian Wang, Xichen Liang, Minglong Chen, Yingming Zhao, Fen Chen, Yunxian Yu, Cynthia C. Taub, Christopher Lee, et al.


  • Top Cited Papers

    Efficacy and Safety of Glucagon-like Peptide-1 Receptor Agonist Use During the First Trimester in Pregnant Women With Type 2 Diabetes

    by Muhammad Hanif, Allison G. Hays, Jai S. Nagarajan, Shiva P. Sah, Ruth S. Weinstock, Cynthia C. Taub


  • Open Access

    Complications of exercise and pharmacologic stress echocardiography

    by Christopher Lee, Sam Dow, Kajal Shah, Stanislav Henkin, Cynthia Taub

    Stress echocardiography is a diagnostic cardiovascular exam that is commonly utilized for multiple indications, including but not limited to the assessment of obstructive coronary artery disease, valvular disease, obstructive hypertrophic cardiomyopathy, and diastolic function. Stress echocardiography can be performed via both exercise and pharmacologic modalities. Exercise stress is performed with either treadmill or bicycle-based exercise. Pharmacologic stress is performed via either dobutamine or vasodilator-mediated (i.e., dipyridamole, adenosine) stress testing. Each of these modalities is associated with a low overall prevalence of major, life-threatening adverse outcomes, though adverse events are most common with dobutamine stress echocardiography. In light of the recent COVID-19 pandemic, the risk of infectious complications to both the patient and stress personnel cannot be negated; however, when certain precautions are taken, the risk of infectious complications appears minimal. In this article, we review each of the stress echocardiographic modalities, examine major potential adverse outcomes and contraindications, assess the risks of stress testing in the setting of a global pandemic, and examine the utilization and safety of stress testing in special patient populations (i.e., language barriers, pediatric patients, pregnancy).


  • Open Access

    Outpatient intravenous diuresis in a rural setting: safety, efficacy, and outcomes

    by Girish Pathangey, Susan P D’aNna, Rohitha A. Moudgal, David B. Min, Katharine A. Manning, Cynthia C. Taub, Lauren G. Gilstrap

    Purpose: To evaluate the safety, efficacy, and outcomes of outpatient intravenous diuresis in a rural setting and compare it to urban outcomes.Methods: A single-center study was conducted on 60 patients (131 visits) at the Dartmouth-Hitchcock Medical Center (DHMC) from 1/2021–12/2022. Demographics, visit data, and outcomes were collected and compared to urban outpatient IV centers, and inpatient HF hospitalizations from DHMC FY21 and national means. Descriptive statistics, T-tests and chi-squares were used.Results: The mean age was 70 ± 13 years, 58% were male, and 83% were NYHA III-IV. Post-diuresis, 5% had mild-moderate hypokalemia, 16% had mild worsening of renal function, and 3% had severe worsening of renal function. No hospitalizations occurred due to adverse events. The mean infusion-visit urine output was 761 ± 521 ml, and post-visit weight loss was −3.9 ± 5.0 kg. No significant differences were observed between HFpEF and HFrEF groups. 30-day readmissions were similar to urban outpatient IV centers, DHMC FY21, and the national mean (23.3% vs. 23.5% vs. 22.2% vs. 22.6%, respectively; p = 0.949). 30-day mortality was similar to urban outpatient IV centers but lower than DHMC FY21 and the national means (1.7% vs. 2.5% vs. 12.3% vs. 10.7%, respectively; p < 0.001). At 60 days, 42% of patients had ≥1 clinic revisit, 41% had ≥1 infusion revisit, 33% were readmitted to the hospital, and two deaths occurred. The clinic avoided 21 hospitalizations, resulting in estimated cost savings of $426,111.Conclusion: OP IV diuresis appears safe and effective for rural HF patients, potentially decreasing mortality rates and healthcare expenses while mitigating rural-urban disparities.


  • Open Access

    Women’s Cardiovascular Health: Prioritizing the Majority Minority

    by Anna E. Bortnick, Edita Pllana, Diana S. Wolfe, Cynthia C. Taub

    Women make up the majority of the global population, and

  • Open Access

    Association between Abnormal Echocardiography and Adverse Obstetric Outcomes in Low-Risk Pregnant Women

    by Kerrilynn C. Hennessey, Thara S. Ali, Eunjung Choi, Alexandra R. Ortengren, Leigh C. Hickerson, Jennifer May Lee, Cynthia C. Taub

    Maternal mortality in the United States is a public health crisis of preventable deaths among young women. The role of echocardiography in the evaluation of pregnant women with cardiovascular symptoms or risk factors without known heart disease is unclear. We retrospectively examined the clinical characteristics of consecutive pregnant patients without established heart disease who underwent echocardiography and evaluated associations between abnormal exam findings and obstetric outcomes. Among low-risk women undergoing echocardiography during pregnancy, older age, higher parity and a history of chronic hypertension are associated with a higher likelihood of echocardiographic abnormalities, which in turn are associated with a higher likelihood of adverse obstetric outcomes including caesarean section and preterm delivery.